Citadel Advisors
CSCI

Citadel Advisors’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Citadel Advisors’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,960
Closed -$33.9K – 15622
2024
Q1 		$33.9K Buy
3,960
+1,459
+58% +$11.2K ﹤0.01% 12573
2023
Q4 		$18.6K Buy
+2,501
New +$18.5K ﹤0.01% 12682
2022
Q3 		– Sell
-1,755
Closed -$35K – 13778
2022
Q2 		$35K Buy
+1,755
New +$43.9K ﹤0.01% 12147
2022
Q1 		– Sell
-1,913
Closed -$68.8K – 14754
2021
Q4 		$68K Buy
1,913
+1,513
+378% +$79.7K ﹤0.01% 13056
2021
Q3 		$30K Sell
400
-118
-23% -$8.38K ﹤0.01% 13575
2021
Q2 		$45K Buy
518
+192
+59% +$18.3K ﹤0.01% 13376
2021
Q1 		$37K Buy
+326
New +$36.1K ﹤0.01% 12996
2020
Q1 		– Sell
-118
Closed -$11K – 10306
2019
Q4 		$11K Sell
118
-33
-22% -$3.08K ﹤0.01% 9001
2019
Q3 		$16K Buy
151
+3
+2% +$650 ﹤0.01% 8989
2019
Q2 		$44K Sell
148
-137
-48% -$48.3K ﹤0.01% 8763
2019
Q1 		$133K Buy
+285
New +$111K ﹤0.01% 8441
2018
Q4 		– Sell
-165
Closed -$29K – 9868
2018
Q3 		$29K Buy
+165
New +$30.3K ﹤0.01% 8939
2018
Q2 		– Sell
-102
Closed -$18.8K – 9374
2018
Q1 		$15K Buy
+102
New +$20K ﹤0.01% 8157
2016
Q2 		– Sell
-143
Closed -$47K – 7507
2016
Q1 		$47K Buy
+143
New +$47.1K ﹤0.01% 6269
2015
Q4 		– Sell
-67
Closed -$58K – 9291
2015
Q3 		$58K Buy
+67
New +$97.5K ﹤0.01% 7470
2015
Q1 		– Sell
-9
Closed -$54K – 8914
2014
Q4 		$54K Buy
+9
New +$75.6K ﹤0.01% 7137

Other funds holding CSCI

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Citadel Advisors's CSCI Position: Q2 2024 in Review

Citadel Advisors sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2024, closing a stake of 3,960 shares — an estimated $33.9K sold.

Citadel Advisors first reported a position in CSCI in Q4 2014 and held it in 16 quarters. The position peaked at $133K in Q1 2019. 13 funds tracked by Wall St. Rank hold CSCI as of Q2 2024.

  • Citadel Advisors reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 3,960 COSCIENS Biopharma Inc. Common Stock shares in Q2 2024, an estimated $33.9K.
  • Citadel Advisors first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2014 and held it in 16 quarters.
  • Citadel Advisors's COSCIENS Biopharma Inc. Common Stock position peaked at $133K in Q1 2019.
  • 13 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.